345 related articles for article (PubMed ID: 9497788)
1. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age.
Lyons D; Roy S; Patel M; Benjamin N; Swift CG
Clin Sci (Lond); 1997 Dec; 93(6):519-25. PubMed ID: 9497788
[TBL] [Abstract][Full Text] [Related]
2. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
Calver A; Collier J; Vallance P
Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
[TBL] [Abstract][Full Text] [Related]
3. Vasoconstrictor sensitivity to noradrenaline and NG-monomethyl-L-arginine in men and women.
Kneale BJ; Chowienczyk PJ; Cockcroft JR; Coltart DJ; Ritter JM
Clin Sci (Lond); 1997 Dec; 93(6):513-8. PubMed ID: 9497787
[TBL] [Abstract][Full Text] [Related]
4. Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide.
Newby DE; Boon NA; Webb DJ
Clin Sci (Lond); 1997 Feb; 92(2):133-8. PubMed ID: 9059313
[TBL] [Abstract][Full Text] [Related]
5. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
[TBL] [Abstract][Full Text] [Related]
6. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
7. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm.
Singh N; Prasad S; Singer DR; MacAllister RJ
Clin Sci (Lond); 2002 May; 102(5):595-600. PubMed ID: 11980580
[TBL] [Abstract][Full Text] [Related]
8. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
9. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
11. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide.
Katz SD; Krum H; Khan T; Knecht M
J Am Coll Cardiol; 1996 Sep; 28(3):585-90. PubMed ID: 8772743
[TBL] [Abstract][Full Text] [Related]
12. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide.
Meredith IT; Currie KE; Anderson TJ; Roddy MA; Ganz P; Creager MA
Am J Physiol; 1996 Apr; 270(4 Pt 2):H1435-40. PubMed ID: 8967386
[TBL] [Abstract][Full Text] [Related]
13. Basal nitric oxide production is impaired in offspring of patients with essential hypertension.
McAllister AS; Atkinson AB; Johnston GD; Hadden DR; Bell PM; McCance DR
Clin Sci (Lond); 1999 Aug; 97(2):141-7. PubMed ID: 10409468
[TBL] [Abstract][Full Text] [Related]
14. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
Krum H; Cranswick N; Pellizzer AM
Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
[TBL] [Abstract][Full Text] [Related]
15. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
16. Flow-mediated nitric oxide activity in the forearm vasculature of premenopausal women.
Anumba DO; Robson SC; Ford GA
Br J Clin Pharmacol; 2002 Mar; 53(3):332-6. PubMed ID: 11874398
[TBL] [Abstract][Full Text] [Related]
17. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
Pretorius M; Brown NJ
J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
[TBL] [Abstract][Full Text] [Related]
18. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
19. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
20. Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation.
Duffy SJ; New G; Harper RW; Meredith IT
Cardiovasc Res; 1999 Aug; 43(3):721-30. PubMed ID: 10690343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
